| Assay ID | Title | Year | Journal | Article |
|---|
| AID392116 | Cytotoxicity against human HOS cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392110 | Cytotoxicity against human HCT15 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392118 | Cytotoxicity against human AsPC1 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392124 | Cytotoxicity against human NCI-H1299 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392121 | Cytotoxicity against human MCF7/DX cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID1251288 | Inhibition of purified reconstituted bovine brain V-ATPase | 2015 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
| Synthesis and structure-activity studies of the V-ATPase inhibitor saliphenylhalamide (SaliPhe) and simplified analogs. |
| AID392127 | Growth inhibition of human HME50T cells at 100 nM | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392125 | Cytotoxicity against human A549 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392109 | Cytotoxicity against human HCT116 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392112 | Cytotoxicity against human SW480 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392115 | Cytotoxicity against human A2058 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392107 | Cytotoxicity against human HepG2 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392123 | Cytotoxicity against human NCI-H460 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392119 | Cytotoxicity against human PANC1 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392120 | Cytotoxicity against human MCF7 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392114 | Cytotoxicity against human SK-MEL-28 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392122 | Cytotoxicity against human MDA-MB-231 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392111 | Cytotoxicity against human HT-29 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392117 | Cytotoxicity against human MG63 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392126 | Cytotoxicity against human SKMES1 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID1251290 | Growth inhibition of human HCC4017 cells assessed as reduction in cell viability at 0.1 nM to 10 uM | 2015 | Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
| Synthesis and structure-activity studies of the V-ATPase inhibitor saliphenylhalamide (SaliPhe) and simplified analogs. |
| AID392113 | Cytotoxicity against human SK-MEL-5 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| AID392108 | Cytotoxicity against human SKHEP1 cells expressing vacuolar ATPase | 2008 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 18, Issue:22
| Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |